Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;76:575-583

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stahl, G. L.
Right arrow Articles by Frendl, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stahl, G. L.
Right arrow Articles by Frendl, G.
(Circulation Research. 1995;76:575-583.)
© 1995 American Heart Association, Inc.


Articles

Complement-Mediated Loss of Endothelium-Dependent Relaxation of Porcine Coronary Arteries

Role of the Terminal Membrane Attack Complex

Gregory L. Stahl, Wende R. Reenstra, Gyorgy Frendl

From Brigham and Women's Hospital (G.L.S., G.F.), Department of Anesthesia, Anesthesia Research Laboratories, Ischemia Reperfusion Center, Boston, Mass; the Department of Internal Medicine (G.L.S.), Division of Cardiovascular Medicine, University of California, Davis; and the Department of Dermatology (W.R.R.), Boston (Mass) University, School of Medicine.

Correspondence to Gregory L. Stahl, PhD, Brigham and Women's Hospital, Department of Anesthesia, Ischemia Reperfusion Center, 75 Francis St, Boston, MA 02115. E-mail gstahl@zeus.bwh.harvard.edu.

Abstract Reperfusion of the ischemic myocardium results in the loss of endothelium-dependent relaxation. We have shown recently that the alternate complement pathway is activated immediately on reperfusion of the ischemic porcine myocardium. We hypothesized that complement activation directly attenuates endothelium-dependent relaxation of porcine coronary arteries. Bradykinin (BK) or substance P concentration-dependently relaxed precontracted (U46619, 50 nmol/L) left anterior descending coronary artery (LAD) rings in vitro. Addition of zymosan to human (10%) or porcine (10%) serum for 30 minutes significantly (P<0.05) increased the EC50 of BK-induced LAD relaxation from 4±1 to 418±159 nmol/L (n=8) and from 9±3 to 281±132 nmol/L (n=7), respectively. Similarly, addition of zymosan to 10% human serum (HS) for 30 minutes increased the EC50 of substance P–induced LAD relaxation from 0.4±0.1 to 30±14 nmol/L (n=9, P<.05). Basal release of nitric oxide was reduced significantly in LAD rings exposed to zymosan-activated HS compared with HS alone. Addition of soluble CR1 (sCR1, 10 nmol/L) to zymosan-activated HS preserved BK-induced relaxation (EC50) of the LAD rings (control, 4±1 nmol/L; sCR1+zymosan+serum, 2±1 nmol/L; n=6). Zymosan-activated C8-depleted HS (10%) did not attenuate the EC50 of BK-induced coronary artery relaxation (3±1 to 3±1 nmol/L, n=7, P=NS). Zymosan-activated C8-depleted HS plus C8 (6 µg/mL) increased the EC50 of BK-induced coronary artery relaxation from 4±1 to 423±141 nmol/L (n=12, P<.05). We have further demonstrated that C5b-9 complexes can be found on the luminal surface of LAD endothelial cells after 5 minutes of exposure to zymosan-activated HS by using C5b-9 reactive monoclonal antibody fluorescent immunohistochemistry and confocal microscopy. We conclude that complement activation directly attenuates endothelium-dependent relaxation through the formation of the terminal membrane attack complex (C5b-9).


Key Words: C5b-9 • soluble complement receptor type 1 • bradykinin • substance P • nitric oxide




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
R. M. Peckham, M. T. Handrigan, T. B. Bentley, M. J Falabella, A. D. Chrovian, G. L. Stahl, and G. C. Tsokos
C5-blocking antibody reduces fluid requirements and improves responsiveness to fluid infusion in hemorrhagic shock managed with hypotensive resuscitation
J Appl Physiol, February 1, 2007; 102(2): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Szebeni, L. Baranyi, S. Savay, M. Bodo, J. Milosevits, C. R. Alving, and R. Bunger
Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1050 - H1058.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. C. Riedemann and P. A. Ward
Complement in Ischemia Reperfusion Injury
Am. J. Pathol., February 1, 2003; 162(2): 363 - 367.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. Agah, M. C. Montalto, C. L. Kiesecker, M. Morrissey, M. Grover, K. L. Whoolery, R. P. Rother, and G. L. Stahl
Isolation, Characterization, and Cloning of Porcine Complement Component C7
J. Immunol., July 15, 2000; 165(2): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. D. Sharma, G. Sreeram, T. Erb, H. P. Grocott, and T. F. Slaughter
Leukocyte-Reduced Blood Transfusions: Perioperative Indications, Adverse Effects, and Cost Analysis
Anesth. Analg., June 1, 2000; 90(6): 1315 - 1323.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. D. Collard, A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Meri, and G. L. Stahl
Complement Activation after Oxidative Stress : Role of the Lectin Complement Pathway
Am. J. Pathol., May 1, 2000; 156(5): 1549 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. W. Park, K. Sato, H. B. Dai, M. E. Comunale, and F. W. Sellke
Epithelium-Dependent Bronchodilatory Activity Is Preserved in Pig Bronchioles After Normothermic Cardiopulmonary Bypass
Anesth. Analg., April 1, 2000; 90(4): 778 - 783.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Tofukuji, G. L. Stahl, C. Metais, M. Tomita, A. Agah, C. Bianchi, M. P. Fink, and F. W. Sellke
Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a
Ann. Thorac. Surg., March 1, 2000; 69(3): 799 - 807.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl
Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2623 - 2629.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. S. Rinder, H. M. Rinder, K. Johnson, M. Smith, D. L. Lee, J. Tracey, G. Polack, P. Higgins, C. G. Yeh, and B. R. Smith MD
Role of C3 Cleavage in Monocyte Activation During Extracorporeal Circulation
Circulation, August 3, 1999; 100(5): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. Stangl, O. Rodiger, T. M. Frank, M. Bohm, K. Stangl, G. Baumann, and S. B. Felix
Influence of polymorphonuclear leukocytes and plasma on coronary vasomotion after ischemia
Ann. Thorac. Surg., August 1, 1999; 68(2): 442 - 446.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. W. Park, M. Tofukuji, C. Metais, M. E. Comunale, H. B. Dai, M. Simons, G. L. Stahl, A. Agah, and F. W. Sellke
Attenuation of Endothelium-Dependent Dilation of Pig Pulmonary Arterioles After Cardiopulmonary Bypass Is Prevented by Monoclonal Antibody to Complement C5a
Anesth. Analg., July 1, 1999; 89(1): 42 - 42.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Tofukuji, C. Metais, C. D. Collard, D. S. Morse, G. L. Stahl, D. P. Nelson, J. Li, M. Simons, and F. W. Sellke
Effect of sialyl Lewisx oligosaccharide on myocardial and cerebral injury in the pig
Ann. Thorac. Surg., January 1, 1999; 67(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Tofukuji, G. L. Stahl, A. Agah, C. Metais, M. Simons, and F. W. Sellke
ANTI-C5A MONOCLONAL ANTIBODY REDUCES CARDIOPULMONARY BYPASS AND CARDIOPLEGIA-INDUCED CORONARY ENDOTHELIAL DYSFUNCTION
J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 1060 - 1069.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. P. Vakeva, A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion : Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy
Circulation, June 9, 1998; 97(22): 2259 - 2267.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Stamler, S. Y. Wang, D. E. Aguirre, R. G. Johnson, and F. W. Sellke
Cardiopulmonary Bypass Alters Vasomotor Regulation of the Skeletal Muscle Microcirculation
Ann. Thorac. Surg., August 1, 1997; 64(2): 460 - 465.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
F. E. Schmidt Jr, M. J. MacDonald, C. O. Murphy, W. M. Brown III, J. P. Gott, and R. A. Guyton
Leukocyte Depletion of Blood Cardioplegia Attenuates Reperfusion Injury
Ann. Thorac. Surg., December 1, 1996; 62(6): 1691 - 1696.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. W. Sellke, S. Y. Wang, A. Stamler, R. G. Johnson, W. E. Cohn, and R. M. Weintraub
CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUESCHANGES IN AUTONOMIC RESPONSE OF THE CEREBRAL CIRCULATION AFTER NORMOTHERMIC EXTRACORPOREAL CIRCULATION
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 450 - 461.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
A. Stamler, S. Y. Wang, J. Li, R. L. Thurer, F. J. Schoen, and F. W. Sellke
Moderate Hypothermia Reduces Cardiopulmonary Bypass-Induced Impairment of Cerebrovascular Responses to Platelet Products
Ann. Thorac. Surg., July 1, 1996; 62(1): 191 - 198.
[Abstract] [Full Text]